Correction: Exploring the Therapeutic Potential of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis in Patients with Type 2 Diabetes: A Narrative Review.
来源：PubMed发布日期：2026-02-17作者：Al Rashid S, Suriyan A, Bilal Azam M, Balasubramanian R, Pakkir Maideen NM0 次点击